Your browser doesn't support javascript.
loading
Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies.
Landgren, Ola; Kazandjian, Dickran; Roussel, Murielle; Jasielec, Jagoda; Dytfeld, Dominik; Anderson, Aparna; Kervin, Tara A; Iskander, Karim; McFadden, Ian; Jakubowiak, Andrzej J.
Afiliação
  • Landgren O; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA.
  • Kazandjian D; National Cancer Institute, Bethesda, MD, USA.
  • Roussel M; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Jasielec J; Internal Medicine - Hematology, University of Chicago, Chicago, IL, USA.
  • Dytfeld D; Department of Hematology, Poznan University of Medical Sciences, Poznan, Poland.
  • Anderson A; Statistics Collaborative, Inc, Washington, DC, USA.
  • Kervin TA; Statistics Collaborative, Inc, Washington, DC, USA.
  • Iskander K; Amgen Inc, Thousand Oaks, CA, USA.
  • McFadden I; Amgen Inc, Thousand Oaks, CA, USA.
  • Jakubowiak AJ; Internal Medicine - Hematology, University of Chicago, Chicago, IL, USA.
Leuk Lymphoma ; 63(10): 2413-2421, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35549810

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article